Correction to Lancet Oncol 2025; 26: 571-82

No authors listed

Published Erratum

No authors listed. Lancet Oncol. 2025 Jul.

. 2025 Jul;26(7):e349.

doi: 10.1016/S1470-2045(25)00354-7.

No abstract available

Erratum for

Belzutifan for von Hippel-Lindau disease-associated renal cell carcinoma and other neoplasms (LITESPARK-004): 50 months follow-up from a single-arm, phase 2 study.
Srinivasan R, Iliopoulos O, Beckermann KE, Narayan V, Maughan BL, Oudard S, Else T, Maranchie JK, Iversen AB, Cornell J, Perini RF, Liu Y, Linehan WM, Jonasch E. Srinivasan R, et al. Lancet Oncol. 2025 May;26(5):571-582. doi: 10.1016/S1470-2045(25)00099-3. Epub 2025 Apr 12. Lancet Oncol. 2025. PMID: 40228516 Clinical Trial.